BAXTER INTERNATIONAL INC acquired Immuno International AG for $600M, a transaction completed in 1997, structured as Acquisition completed in the first fiscal quarter of 1997; approximately $600 million plus assumption of about $280 million of net debt.
Immuno International AG operates in BioScience, is based in Vienna, Austria. Baxter acquired Immuno International AG, a Vienna, Austria-based global manufacturer of biopharmaceutical products and services for transfusion medicine, including plasma-derived products for hemophilia and surgical applications. The combination created one of the world's largest manufacturers of plasma products; U.S. antitrust clearance required certain divestitures and licensing commitments.
Expanded Baxter's plasma-derived biopharmaceuticals and transfusion-medicine portfolio, creating a leading global plasma products manufacturer.
Advisory firms were not disclosed for this transaction.